Bellerophon Therapeutics
| Region | Nordamerika |
| ISIN | US0787713009 |
| Sektor | Medizintechnik, Biotech |
| Website | https://bellerophon.com/ |
Bellerophon is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases.
| Titel | Autor | Datum |
|---|---|---|
|
NO to COVID!
|
rotten.tom | vor ungefähr 2 Jahren |
| Titel | Datum |
|---|---|
| Bellerophon Therapeutics GAAP EPS of -$0.53 beats by $0.05 | vor 17 Tagen |
| Bellerophon Therapeutics, Inc. - 10-Q, Quarterly Report | vor 17 Tagen |
|
Bellerophon Therapeutics, Inc.: Bellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial Results
WARREN, N.J., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) ("... |
vor 17 Tagen |
| Bellerophon (BLPH) Receives FDA Acceptance to Reduce Study Size | vor ungefähr 2 Monaten |
| Bellerophon stock gains ~24% after getting FDA nod to reduce phase 3 study size | vor ungefähr 2 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Bee Vectoring Technologies (1 Artikel) | |
| Bayer (1 Artikel) | |
| Benz Mining (1 Artikel) | |
| Berkeley Energia (1 Artikel) | |
| Alle anzeigen | |